Exploration of predictors associated with bleeding in computed tomography-guided core needle splenic biopsy: A retrospective study
Authors:
- Sakue MasudaSMSakue Masuda
- Toshitaka TsukiyamaTTToshitaka Tsukiyama
- Ryo Rt DaigoRDRyo Rt Daigo
- Makomo MakazuMMMakomo Makazu
- Ryuhei JinushiRJRyuhei Jinushi
- Kazuya KoizumiKKKazuya Koizumi
- Takashi NishinoTNTakashi Nishino
- Kento ShionoyaKSKento Shionoya
- Karen KimuraKKKaren Kimura
- Chihiro SumidaCSChihiro Sumida
- Jun KubotaJKJun Kubota
- Chikamasa IchitaCIChikamasa Ichita
Open Access
- 17 November 2023
- journal article
- research article
- Published by Wolters Kluwer Health in Medicine
- Vol. 102 (46) , e34951
Abstract
Splenic diseases may be caused by infections and can be either malignant, such as lymphoma and lung cancer, or benign, such as hemangioma. In some cases, diagnostic uncertainty of imaging persists, and image-guided splenic needle biopsy is a useful diagnostic tool to avoid the disadvantages of incorrect diagnosis, including performing unnecessary splenectomy or not giving the necessary treatment. Splenic biopsies can be divided into ultrasound-guided, computed tomography (CT)-guided fine-needle aspiration, or core needle biopsy (CNB). However, few studies have focused exclusively on complications associated with CT-guided CNB of the spleen. Therefore, we assessed bleeding, the most common complication of CT-guided CNB of the spleen, and evaluated factors associated with the bleeding. Using the biopsy database maintained at the institution, all patients who underwent CT-guided CNB of the spleen between May 2012 and September 2022 were identified retrospectively. The 18 identified patients were divided into post-biopsy bleeding and non-bleeding groups for analysis. In total, 17 patients (94.4%) could be diagnosed accurately with CT-guided CNB. Bleeding complications occurred in 7 cases of CT-guided CNB; of these, 2 patients with Common Terminology Criteria for Adverse Events grade 4 disease required transcatheter arterial embolization. The bleeding group was characterized by diffuse spleen tumors in all cases, with significantly more diffuse spleen tumors than the non-bleeding group. CT-guided CNB is a useful option for neoplastic lesions of the spleen that are difficult to diagnose using imaging alone. However, consideration should be given to post-biopsy bleeding in patients with diffuse splenic tumors.Keywords
This publication has 19 references indexed in Scilit:
- Imaging Findings of Primary Splenic Lymphoma: A Review of 17 Cases in Which Diagnosis Was Made at SplenectomyPLOS ONE, 2013
- Investigation of the freely available easy-to-use software ‘EZR’ for medical statisticsBone Marrow Transplantation, 2012
- Society of Interventional Radiology Clinical Practice GuidelinesJournal of Vascular and Interventional Radiology, 2009
- A study to evaluate the efficacy of image-guided core biopsy in the diagnosis and management of lymphoma—Results in 103 biopsiesEuropean Journal of Radiology, 2008
- Percutaneous Image-guided Splenic Biopsy in the Oncology Patient: An Audit of 156 Consecutive CasesJournal of Vascular and Interventional Radiology, 2008
- Image guided percutaneous splenic interventionsEuropean Journal of Radiology, 2007
- Imaging-Guided Percutaneous Splenic Biopsy Using a 20- or 22-Gauge Cutting-Edge Core Biopsy Needle for the Diagnosis of Malignant LymphomaAmerican Journal of Roentgenology, 2003
- Percutaneous Nonvascular Splenic Intervention: A 10-Year ReviewAmerican Journal of Roentgenology, 2002
- Percutaneous CT-Guided Drainage of Splenic AbscessAmerican Journal of Roentgenology, 2002
- Ultrasound‐guided fine needle biopsy of the spleen: High clinical efficacy and low risk in a multicenter Italian studyAmerican Journal of Hematology, 2001